Hopital Haut-Leveque
About Hopital Haut-Leveque
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Hospital, Bordeaux
29
Celgene
25
Groupe Francophone des Myelodysplasies
15
Gilead Sciences
14
Janssen Research & Development, LLC
14
Federation Francophone de Cancerologie Digestive
12
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
12
Ipsen
12
Pfizer
11
The Lymphoma Academic Research Organisation
11
Abbott Medical Devices
10
Clinical Trials at Hopital Haut-Leveque
During the past decade, Hopital Haut-Leveque conducted 276 clinical trials. In the 10-year time frame, 276 clinical trials started and 94 clinical trials were completed, i.e. on
average, 34.1% percent of trials that started reached the finish line to date. In the past 5 years, 110 clinical trials started and 51 clinical trials were completed. i.e. 46.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
1,000
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
1993-03-01
Unknown status
280
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
1999-12-01
2002-01-01
Completed
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
2000-06-01
Unknown status
1,258
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hopital Haut-Leveque" #1 sponsor was "University Hospital, Bordeaux" with 29 trials, followed by "Celgene" with 25 trials
sponsored, "Groupe Francophone des Myelodysplasies" with 15 trials sponsored, "Gilead Sciences" with 14 trials sponsored and "Janssen Research & Development, LLC"
with 14 trials sponsored. Other sponsors include 403 different institutions and
companies that sponsored additional 180 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Haut-Leveque"
#1 collaborator was "Novartis" with 7 trials as a collaborator, "AbbVie" with 5 trials as a collaborator, "Celgene" with 5 trials as a collaborator, "Celgene Corporation" with 5 trials as a collaborator and "Ministry of Health, France" with 5 trials as a collaborator. Other collaborators include 181 different institutions and companies that were
collaborators in the rest 144 trials.
Clinical Trials Conditions at Hopital Haut-Leveque
According to Clinical.Site data, the most researched conditions in "Hopital Haut-Leveque" are
"Multiple Myeloma" (23 trials), "Ulcerative Colitis" (16 trials), "Acute Myeloid Leukemia" (13 trials), "Myelodysplastic Syndromes" (12 trials) and "Atrial Fibrillation" (11 trials). Many other conditions were trialed in "Hopital Haut-Leveque" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Haut-Leveque
Most popular intervention types in "Hopital Haut-Leveque" are "Drug" (346 trials), "Device" (72 trials), "Other" (50 trials), "Procedure" (30 trials) and "Biological" (28 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (66 trials), "Lenalidomide" (16 trials), "Dexamethasone" (13 trials), "Rituximab" (12 trials) and "Azacitidine" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Haut-Leveque
The vast majority of trials in "Hopital Haut-Leveque" are
501 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Hopital Haut-Leveque
Currently, there are 195 active trials in "Hopital Haut-Leveque".
5 are not yet recruiting,
111 are recruiting,
77 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 235 completed trials in Hopital Haut-Leveque,
1 suspended trials,
and 41 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Haut-Leveque, 38 "Phase 1"
clinical trials were conducted, 151 "Phase 2" clinical
trials and 174 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 22 trials, and there were
also 74 trials that are defined as “Not Applicable".